Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Kebebew Website

Electron Kebebew, M.D., F.A.C.S

Selected Publications

1)  Zhang L, Gaskins K, Yu Z, Xiong Y, Merino MJ, Kebebew E.
An in vivo mouse model of metastatic human thyroid cancer.
Thyroid. 24: 695-704, 2014.
2)  Weisbrod AB, Kitano M, Thomas F, Williams D, Gulati N, Gesuwan K, Liu Y, Venzon D, Turkbey I, Choyke P, Yao J, Libutti SK, Nilubol N, Linehan WM, Kebebew E.
Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome.
J. Am. Coll. Surg. 218: 163-9, 2014.
3)  Lee P, Werner CD, Kebebew E, Celi FS.
Functional thermogenic beige adipogenesis is inducible in human neck fat.
Int J Obes (Lond). 38: 170-6, 2014.
4)  Ellis RJ, Wang Y, Stevenson HS, Boufraqech M, Patel D, Nilubol N, Davis S, Edelman DC, Merino MJ, He M, Zhang L, Meltzer PS, Kebebew E.
Genome-wide methylation patterns in papillary thyroid cancer are distinct based on histological subtype and tumor genotype.
J. Clin. Endocrinol. Metab. 99: E329-37, 2014.
5)  Desai SS, Modali SD, Parekh VI, Kebebew E, Agarwal SK.
GSK-3ß protein phosphorylates and stabilizes HLXB9 protein in insulinoma cells to form a targetable mechanism of controlling insulinoma cell proliferation.
J. Biol. Chem. 289: 5386-98, 2014.
6)  Lee P, Linderman JD, Smith S, Brychta RJ, Wang J, Idelson C, Perron RM, Werner CD, Phan GQ, Kammula US, Kebebew E, Pacak K, Chen KY, Celi FS.
Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans.
Cell Metab. 19: 302-9, 2014.
7)  Peng H, Talebzadeh-Farrooji M, Osborne MJ, Prokop JW, McDonald PC, Karar J, Hou Z, He M, Kebebew E, Orntoft T, Herlyn M, Caton AJ, Fredericks W, Malkowicz B, Paterno CS, Carolin AS, Speicher DW, Skordalakes E, Huang Q, Dedhar S, Borden KL, Rauscher FJ.
LIMD2 is a small LIM-only protein overexpressed in metastatic lesions that regulates cell motility and tumor progression by directly binding to and activating the integrin-linked kinase.
Cancer Res. 74: 1390-403, 2014.
8)  Nilubol N, Boufraqech M, Zhang L, Kebebew E.
Loss of CPSF2 expression is associated with increased thyroid cancer cellular invasion and cancer stem cell population, and more aggressive disease.
J. Clin. Endocrinol. Metab. jc20134140, 2014.
9)  Boufraqech M, Zhang L, Jain M, Patel D, Ellis R, Xiong Y, He M, Nilubol N, Merino M, Kebebew E.
miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3.
Endocr. Relat. Cancer. [Epub ahead of print], 2014.
10)  Liu Y, Sadowski SM, Weisbrod AB, Kebebew E, Summers RM, Yao J.
Patient specific tumor growth prediction using multimodal images.
Med Image Anal. 18: 555-66, 2014.
Click Here to View Expanded Bibliography.

This page was last updated on 5/2/2014.